Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Generational differences in current sexual behavior among Georgian reproductive-aged women.

Abzianidze T, Butsashvili M, Kajaia M, DeHovitz JA, Kamkamidze G.

Int J Womens Health. 2019 May 6;11:301-308. doi: 10.2147/IJWH.S197473. eCollection 2019.

2.

Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and Acceptability.

Patel AS, Goparaju L, Sales JM, Mehta CC, Blackstock OJ, Seidman D, Ofotokun I, Kempf MC, Fischl MA, Golub ET, Adimora AA, French AL, DeHovitz J, Wingood G, Kassaye S, Sheth AN.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):527-532. doi: 10.1097/QAI.0000000000001950.

3.

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia.

Karkashadze E, Dvali N, Bolokadze N, Sharvadze L, Gabunia P, Karchava M, Tchelidze T, Tsertsvadze T, DeHovitz J, Del Rio C, Chkhartishvili N.

J Med Virol. 2019 Feb;91(2):235-240. doi: 10.1002/jmv.25245. Epub 2018 Oct 17.

PMID:
29905958
4.

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy.

Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall.

5.

Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.

Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG; Women’s Interagency HIV Study.

Clin Infect Dis. 2017 Oct 30;65(10):1695-1702. doi: 10.1093/cid/cix643.

6.

The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.

Park SY, Love TMT, Reynell L, Yu C, Kang TM, Anastos K, DeHovitz J, Liu C, Kober KM, Cohen M, Mack WJ, Lee HY.

Sci Rep. 2017 Aug 7;7(1):7480. doi: 10.1038/s41598-017-07490-4.

7.

Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV.

Baxi SM, Greenblatt RM, Bacchetti P, Cohen M, DeHovitz JA, Anastos K, Gange SJ, Young MA, Aouizerat BE.

Pharmacogenomics J. 2018 Apr;18(2):245-250. doi: 10.1038/tpj.2017.3. Epub 2017 May 2.

PMID:
28462920
8.

Patterns of harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine: A two-part latent profile analysis.

Ompad DC, Wang J, Dumchev K, Barska J, Samko M, Zeziulin O, Saliuk T, Varetska O, DeHovitz J.

Int J Drug Policy. 2017 May;43:7-15. doi: 10.1016/j.drugpo.2016.12.008. Epub 2017 Feb 1.

9.

Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013.

Makarenko I, Ompad DC, Sazonova Y, Saliuk T, DeHovitz J, Gensburg L.

J Urban Health. 2017 Feb;94(1):104-114. doi: 10.1007/s11524-016-0119-9.

10.

Pharmacogenetic Associations with ADME Variants and Virologic Response to an Initial HAART Regimen in HIV-Infected Women.

Pearce CL, Stram D, Wiensch A, Frasco MA, Kono N, Den Berg DV, Anastos K, Cohen MH, DeHovitz J, Golub ET, Tamraz B, Liu C, Mack WJ.

Int J HIV AIDS Res. 2017;4(3):154-160. doi: 10.19070/2379-1586-1700031. Epub 2017 Sep 5.

11.

Factors Associated with Delayed Enrollment in HIV Medical Care among HIV-Positive Individuals in Odessa Region, Ukraine.

Neduzhko O, Postnov O, Perehinets I, DeHovitz J, Joseph M, Odegaard D, Kaplan R, Kiriazova T.

J Int Assoc Provid AIDS Care. 2017 Mar/Apr;16(2):168-173. doi: 10.1177/2325957416686194. Epub 2016 Dec 30.

12.

Assessment of quality of life in people living with HIV in Georgia.

Karkashadze E, Gates MA, Chkhartishvili N, DeHovitz J, Tsertsvadze T.

Int J STD AIDS. 2017 Jun;28(7):672-678. doi: 10.1177/0956462416662379. Epub 2016 Jul 26.

13.

A Comparison of Methods for Analyzing Viral Load Data in Studies of HIV Patients.

Rose CE, Gardner L, Craw J, Girde S, Wawrzyniak AJ, Drainoni ML, Davila J, DeHovitz J, Keruly JC, Westfall AO, Marks G.

PLoS One. 2015 Jun 19;10(6):e0130090. doi: 10.1371/journal.pone.0130090. eCollection 2015.

14.

The cascade of care in the Eastern European country of Georgia.

Chkhartishvili N, Sharavdze L, Chokoshvili O, DeHovitz JA, del Rio C, Tsertsvadze T.

HIV Med. 2015 Jan;16(1):62-6. doi: 10.1111/hiv.12172. Epub 2014 Jun 12.

15.

Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia.

Chkhartishvili N, Rukhadze N, Svanidze M, Sharvadze L, Dehovitz JA, Tsertsvadze T, McNutt LA, del Rio C.

J Int AIDS Soc. 2014 Apr 9;17:18885. doi: 10.7448/IAS.17.1.18885. eCollection 2014.

16.

The HIV epidemic in Eastern Europe and Central Asia.

DeHovitz J, Uuskula A, El-Bassel N.

Curr HIV/AIDS Rep. 2014 Jun;11(2):168-76. doi: 10.1007/s11904-014-0202-3.

PMID:
24652411
17.

The potential for bridging: HIV status awareness and risky sexual behaviour of injection drug users who have non-injecting permanent partners in Ukraine.

Mazhnaya A, Andreeva TI, Samuels S, DeHovitz J, Salyuk T, McNutt LA.

J Int AIDS Soc. 2014 Feb 17;17:18825. doi: 10.7448/IAS.17.1.18825. eCollection 2014.

18.

Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989-2012.

Chkhartishvili N, Sharvadze L, Chokoshvili O, Bolokadze N, Rukhadze N, Kempker RR, Gamkrelidze A, DeHovitz JA, Del Rio C, Tsertsvadze T.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):560-6. doi: 10.1089/AID.2013.0219. Epub 2014 Feb 24.

19.

Refining HIV risk: the modifying effects of youth, gender and education among people who inject drugs in Poland.

Czerwinski M, McNutt LA, DeHovitz JA, Zielinski A, Rosinska M.

PLoS One. 2013 Jul 23;8(7):e68018. doi: 10.1371/journal.pone.0068018. Print 2013.

20.

HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation.

Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, DeHovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP; INSIGHT SMART Study Team.

J Am Heart Assoc. 2013 Jul 29;2(4):e000264. doi: 10.1161/JAHA.113.000264.

21.

Mean platelet volume is decreased in HIV-infected women.

Qadri S, Holman S, Dehovitz J, Crystal H, Minkoff H, Lazar JM.

HIV Med. 2013 Oct;14(9):549-55. doi: 10.1111/hiv.12048. Epub 2013 Jun 5.

22.

Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia.

Laisaar KT, Uusküla A, Sharma A, DeHovitz JA, Amico KR.

AIDS Care. 2013;25(7):863-73. doi: 10.1080/09540121.2013.764393. Epub 2013 Feb 7.

23.

Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women.

Estrella MM, Abraham AG, Jing Y, Parekh RS, Tien PC, Merenstein D, Pearce CL, Anastos K, Cohen MH, Dehovitz JA, Gange SJ.

AIDS Res Hum Retroviruses. 2013 May;29(5):755-60. doi: 10.1089/AID.2012.0248. Epub 2013 Jan 29.

24.

Associated factors for recommending HBV vaccination to children among Georgian health care workers.

Butsashvili M, Kamkamidze G, Topuridze M, Morse D, Triner W, DeHovitz J, Nelson K, McNutt LA.

BMC Infect Dis. 2012 Dec 20;12:362. doi: 10.1186/1471-2334-12-362.

25.

A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.

Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B; Women's Interagency HIV Study.

J Infect Dis. 2012 Nov;206(9):1453-61. doi: 10.1093/infdis/jis508. Epub 2012 Aug 20.

26.

Occupational exposure to body fluids among health care workers in Georgia.

Butsashvili M, Kamkamidze G, Kajaia M, Morse DL, Triner W, Dehovitz J, McNutt LA.

Occup Med (Lond). 2012 Dec;62(8):620-6. doi: 10.1093/occmed/kqs121. Epub 2012 Aug 6.

27.

Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia.

Dvali N, Parker MM, Chkhartishvili N, Sharvadze L, Gochitashvili N, Abutidze A, Karchava M, DeHovitz JA, Tsertsvadze T.

J Med Virol. 2012 Jul;84(7):1002-8. doi: 10.1002/jmv.23269.

PMID:
22585715
28.

Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia.

Uusküla A, Laisaar KT, Raag M, Šmidt J, Semjonova S, Kogan J, Amico KR, Sharma A, Dehovitz J.

AIDS Care. 2012;24(12):1470-9. doi: 10.1080/09540121.2012.672724. Epub 2012 Apr 25.

PMID:
22533736
29.

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia.

Tsertsvadze T, Chkhartishvili N, Sharvadze L, Dvali N, Chokoshvili O, Gabunia P, Abutidze A, Nelson K, Dehovitz J, Del Rio C.

AIDS Res Treat. 2011;2011:621078. doi: 10.1155/2011/621078. Epub 2011 Feb 21.

30.

Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women.

Delwart E, Bernardin F, Lee TH, Winkelman V, Liu C, Sheppard H, Liu A, Greenblatt R, Anastos K, DeHovitz J, Nowicki M, Cohen M, Golub ET, Barbour J, Buchbinder S, Busch MP; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI).

AIDS. 2011 Mar 13;25(5):619-23. doi: 10.1097/QAD.0b013e3283440269.

31.

The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women.

Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):253-62. doi: 10.1097/QAI.0b013e31820a9d04.

32.

Estonia at the threshold of the fourth decade of the AIDS era in Europe.

Laisaar KT, Avi R, DeHovitz J, Uusküla A.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):841-51. doi: 10.1089/AID.2010.0223. Epub 2011 Jan 11.

33.

Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study.

Glesby MJ, Hoover DR, Shi Q, Danoff A, Howard A, Tien P, Merenstein D, Cohen M, Golub E, Dehovitz J, Nowicki M, Anastos K.

Antivir Ther. 2010;15(4):571-7. doi: 10.3851/IMP1557.

34.

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):217-20. doi: 10.1097/QAI.0b013e3181e674f4.

35.

Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Uusküla A, Kals M, Kosenkranius L, McNutt LA, DeHovitz J J.

BMC Infect Dis. 2010 Mar 11;10:63. doi: 10.1186/1471-2334-10-63.

36.

Racial variations in care and outcomes for inpatient HIV-related pneumocystis pneumonia.

Parada JP, Yarnold PR, Uphold CR, Chmiel JS, DeHovitz JA, Goetz MB, Weinstein RA, McKoy JM, Chandler KL, Bennett CL.

J Health Care Poor Underserved. 2010 Feb;21(1):318-33. doi: 10.1353/hpu.0.0249.

PMID:
20173272
37.

Trends in the epidemiology of bacterial sexually transmitted infections in eastern Europe, 1995-2005.

Uusküla A, Puur A, Toompere K, DeHovitz J.

Sex Transm Infect. 2010 Feb;86(1):6-14. doi: 10.1136/sti.2009.037044. Review.

PMID:
20157177
38.

Czech health two decades on from the Velvet Revolution.

Antonova P, Jacobs DI, Bojar M, Cerný R, Ciharová K, Frick MA, Fintel B, DeHovitz J, Bennett CL.

Lancet. 2010 Jan 16;375(9710):179-81. doi: 10.1016/S0140-6736(09)61293-9. Epub 2009 Nov 11. No abstract available.

39.

Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women.

Mansoor A, Althoff K, Gange S, Anastos K, Dehovitz J, Minkoff H, Kaplan R, Holman S, Lazar JM.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):997-1004. doi: 10.1089/aid.2009.0038.

40.

Risk factors of mortality in septic newborns in neonatal intensive care units (NICUs) in Tbilisi, the Republic of Georgia.

Butsashvili M, Kourbatova E, Macharashvili N, Kamkamidze G, McNutt LA, Dehovitz J, Leonard MK.

Eur J Epidemiol. 2009;24(8):477-9. doi: 10.1007/s10654-009-9360-9. Epub 2009 Jun 14. No abstract available.

41.

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC.

J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09. Epub 2009 May 13.

42.

The association of HIV infection with left ventricular mass/hypertrophy.

Mansoor A, Golub ET, Dehovitz J, Anastos K, Kaplan RC, Lazar JM.

AIDS Res Hum Retroviruses. 2009 May;25(5):475-81. doi: 10.1089/aid.2008.0170.

43.

Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):369-76.

44.

The prevalence of chlamydial infection in Estonia: a population-based survey.

Uusküla A, Kals M, Denks K, Nurm U, Kasesalu L, Dehovitz J, McNutt LA.

Int J STD AIDS. 2008 Jul;19(7):455-8. doi: 10.1258/ijsa.2008.007325.

45.

Interarm blood pressure differences in the women's interagency HIV study.

Lazar J, Holman S, Minkoff HL, Dehovitz JA, Sharma A.

AIDS Res Hum Retroviruses. 2008 May;24(5):695-700. doi: 10.1089/aid.2007.0237.

PMID:
18507529
46.

High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.

Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, Rüütel K, Platt L, Rhodes T, Dehovitz J, Des Jarlais D.

J Public Health (Oxf). 2008 Jun;30(2):119-25. doi: 10.1093/pubmed/fdn014. Epub 2008 Feb 28.

47.

Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.

Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83. doi: 10.1097/QAI.0b013e318160d552.

PMID:
18176324
48.

Peripheral arterial disease in HIV-infected and uninfected women.

Sharma A, Holman S, Pitts R, Minkoff HL, Dehovitz JA, Lazar J.

HIV Med. 2007 Nov;8(8):555-60.

49.

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

AIDS. 2007 Aug 20;21(13):1739-45.

PMID:
17690572
50.

Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients.

Campo RE, Narayanan S, Clay PG, Dehovitz J, Johnson D, Jordan W, Squires KE, Sajjan SG, Markson LE.

AIDS Patient Care STDS. 2007 May;21(5):329-38.

PMID:
17518525

Supplemental Content

Loading ...
Support Center